OXA-48-producing Enterobacteriaceae causing bacteremia, United Arab Emirates.
作者信息
Ahn Chulsoo, Butt Adeel A, Rivera Jesabel I, Yaqoob Maidah, Hag Sara, Khalil Alaa, Pitout Marthinus, Doi Yohei
机构信息
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Department of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
出版信息
Int J Infect Dis. 2015 Jan;30:36-7. doi: 10.1016/j.ijid.2014.11.008. Epub 2014 Nov 13.
Abstract
OXA-48-producing isolates were identified in approximately 4% and less than 1% of ESBL-producing and non-ESBL-producing E. coli and K. pneumoniae causing bacteremia at the largest tertiary hospital in Abu Dhabi.
摘要
相似文献
1
OXA-48-producing Enterobacteriaceae causing bacteremia, United Arab Emirates.
Int J Infect Dis. 2015 Jan;30:36-7. doi: 10.1016/j.ijid.2014.11.008. Epub 2014 Nov 13.
2
Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae causing intra-abdominal infections from 9 tertiary hospitals in China.
Diagn Microbiol Infect Dis. 2017 Jan;87(1):45-48. doi: 10.1016/j.diagmicrobio.2016.10.007. Epub 2016 Oct 7.
3
Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Med Mal Infect. 2013 Aug;43(8):331-6. doi: 10.1016/j.medmal.2013.06.001. Epub 2013 Jul 19.
4
High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
Diagn Microbiol Infect Dis. 2016 Jun;85(2):221-6. doi: 10.1016/j.diagmicrobio.2016.03.009. Epub 2016 Mar 8.
5
Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
J Microbiol Immunol Infect. 2012 Jun;45(3):193-9. doi: 10.1016/j.jmii.2011.11.003. Epub 2012 May 12.
6
Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.
Eur J Clin Microbiol Infect Dis. 2017 Jan;36(1):139-146. doi: 10.1007/s10096-016-2782-x. Epub 2016 Sep 17.
7
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Microb Drug Resist. 2015 Apr;21(2):244-51. doi: 10.1089/mdr.2014.0092. Epub 2014 Nov 14.
8
Isolation of OXA-181 Carbapenemase-Producing Escherichia coli and OXA-232 Carbapenemase-Producing Klebsiella pneumoniae from a Pregnant Woman Returning to Japan from India.
Jpn J Infect Dis. 2019 Jul 24;72(4):281-283. doi: 10.7883/yoken.JJID.2018.432. Epub 2019 May 31.
9
Multicentre investigation of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in German hospitals.
Int J Med Microbiol. 2016 Sep;306(6):415-20. doi: 10.1016/j.ijmm.2016.05.009. Epub 2016 May 13.
10
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
J Antimicrob Chemother. 2013 May;68 Suppl 1:i57-65. doi: 10.1093/jac/dkt027.
引用本文的文献
1
Bacteremia in the Gulf Cooperation Council Region: A Review of the Literature 2013-2023.
Infect Drug Resist. 2025 May 7;18:2329-2355. doi: 10.2147/IDR.S497241. eCollection 2025.
2
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.
Antimicrob Agents Chemother. 2022 Aug 16;66(8):e0021622. doi: 10.1128/aac.00216-22. Epub 2022 Jul 20.
3
Antibiotic-Resistance Genes in strains in GCC Countries: A Meta-Analysis.
Saudi J Med Med Sci. 2022 Jan-Apr;10(1):1-11. doi: 10.4103/sjmms.sjmms_638_21. Epub 2022 Jan 17.
4
Treatment of Infections by OXA-48-Producing Enterobacteriaceae.
Antimicrob Agents Chemother. 2018 Oct 24;62(11). doi: 10.1128/AAC.01195-18. Print 2018 Nov.
5
The global epidemiology of carbapenemase-producing Enterobacteriaceae.
Virulence. 2017 May 19;8(4):460-469. doi: 10.1080/21505594.2016.1222343. Epub 2016 Aug 11.
6
Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods.
Front Microbiol. 2016 Jun 13;7:895. doi: 10.3389/fmicb.2016.00895. eCollection 2016.
7
Characterization of Carbapenem-Resistant Enterobacteriaceae with High Rate of Autochthonous Transmission in the Arabian Peninsula.
PLoS One. 2015 Jun 25;10(6):e0131372. doi: 10.1371/journal.pone.0131372. eCollection 2015.
本文引用的文献
1
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.
Antimicrob Agents Chemother. 2014 Jun;58(6):3085-90. doi: 10.1128/AAC.02050-13. Epub 2014 Mar 17.
2
High incidence of New Delhi metallo-beta-lactamase-producing Klebsiella pneumoniae isolates in Sharjah, United Arab Emirates.
Microb Drug Resist. 2014 Feb;20(1):52-6. doi: 10.1089/mdr.2013.0040. Epub 2013 Aug 30.
3
Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011.
Euro Surveill. 2013 Aug 1;18(31):20549. doi: 10.2807/1560-7917.es2013.18.31.20549.
4
β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.
Clin Microbiol Rev. 2013 Jul;26(3):361-80. doi: 10.1128/CMR.00096-12.
5
Emergence and spread of NDM-1 producer Enterobacteriaceae with contribution of IncX3 plasmids in the United Arab Emirates.
J Med Microbiol. 2013 Jul;62(Pt 7):1044-1050. doi: 10.1099/jmm.0.059014-0. Epub 2013 Apr 11.
6
Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: spread of clonal complex 11 (ST11, ST437 and ST340).
J Antimicrob Chemother. 2013 Feb;68(2):312-6. doi: 10.1093/jac/dks396. Epub 2012 Oct 15.
7
A mosaic transposon encoding OXA-48 and CTX-M-15: towards pan-resistance.
J Antimicrob Chemother. 2013 Feb;68(2):476-7. doi: 10.1093/jac/dks397. Epub 2012 Sep 30.
8
Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome.
Antimicrob Agents Chemother. 2012 Jan;56(1):420-7. doi: 10.1128/AAC.05036-11. Epub 2011 Oct 17.
9
The characteristics of NDM-producing Klebsiella pneumoniae from Canada.
Diagn Microbiol Infect Dis. 2011 Oct;71(2):106-9. doi: 10.1016/j.diagmicrobio.2011.06.013.
Zotero 插件